Peris J, Dwoskin L P, Zahniser N R
Department of Pharmacology, University of Colorado Health Sciences Center, Denver 80262.
Synapse. 1988;2(4):450-6. doi: 10.1002/syn.890020413.
It has been hypothesized that dopamine (DA) inhibits glutamate release from corticostriatal fibers via presynaptically located D-2 DA receptors although the evidence presented in the literature has not been conclusive. In the present experiments, the effect of D-2 receptor ligands on K+-stimulated tritium release from rat striatal slices preloaded with the nonmetabolizable glutamate analog [3H]D-aspartate ([3H]ASP was measured. The D-2 receptor antagonist S-sulpiride increased stimulated [3H]ASP release by 75% (EC50 value = 240 nM) and the biologically less-active isomer R-sulpiride, although equally effective, was tenfold less potent. The D-2 receptor agonists pergolide and (+)-4-propyl-9-hydroxynapthoxazine (+PHNO) inhibited [3H]ASP release at nM concentrations; however, this effect was small (20%). This low efficacy of the exogenous agonists was apparently due to competition by high concentrations of endogenous DA since the effect of pergolide was increased in rats whose striatal DA levels were decreased by 97%. These data support the hypothesis that D-2 DA receptors modulate [3H]ASP release in an inhibitory fashion. However, when the agonists were tested at lower concentrations, [3H]ASP release was increased significantly by 20% in control rats and 60% in DA-depleted rats. Both the facilitory and inhibitory effects of pergolide were blocked by 10 microM S-sulpiride, suggesting D-2 receptor mediation. In addition, the facilitory effect of pergolide was blocked by tetrodotoxin (TTX) and by the GABAA antagonist bicuculline, implying mediation of this D-2 effect by an inhibitory GABAergic interneuron. The inhibitory effect of pergolide was decreased by the muscarinic antagonist atropine.(ABSTRACT TRUNCATED AT 250 WORDS)
据推测,多巴胺(DA)通过位于突触前的D-2多巴胺受体抑制皮质纹状体纤维释放谷氨酸,尽管文献中给出的证据尚无定论。在本实验中,测定了D-2受体配体对预先加载不可代谢谷氨酸类似物[3H]D-天冬氨酸([3H]ASP)的大鼠纹状体切片中钾离子刺激的氚释放的影响。D-2受体拮抗剂S-舒必利使刺激的[3H]ASP释放增加了75%(半数有效浓度值=240 nM),生物活性较低的异构体R-舒必利虽然同样有效,但效力低10倍。D-2受体激动剂培高利特和(+)-4-丙基-9-羟基萘并恶嗪(+PHNO)在纳摩尔浓度下抑制[3H]ASP释放;然而,这种作用很小(2%)。外源性激动剂的这种低效性显然是由于高浓度内源性DA的竞争,因为在纹状体DA水平降低97%的大鼠中,培高利特的作用增强。这些数据支持D-2多巴胺受体以抑制方式调节[3H]ASP释放的假说。然而,当在较低浓度下测试激动剂时,对照大鼠的[3H]ASP释放显著增加20%,DA耗竭大鼠中增加60%。培高利特的促进和抑制作用均被10 microM S-舒必利阻断,提示由D-2受体介导。此外,培高利特的促进作用被河豚毒素(TTX)和GABAA拮抗剂荷包牡丹碱阻断,这意味着这种D-2效应是由抑制性GABA能中间神经元介导的。培高利特的抑制作用被毒蕈碱拮抗剂阿托品减弱。(摘要截取自250字)